How to buy Visa (V) stock from India
Buying Visa stock from India is fully legal via the LRS. Here's the mechanics, the capital-gains and dividend math that actually matter, and the estate-tax trap most Indians miss.
Yes, an Indian resident can buy Visa — legally, in US dollars, under the RBI's Liberalised Remittance Scheme (LRS). The buying takes ten minutes. The work is the dividend-withholding math, the capital-gains rules, and the estate-tax exposure most Indians miss. Here's the short version.
Live data via TradingView, in USD and possibly delayed. Shown for information only — not a quote, recommendation, or investment advice.
Wall Street analyst consensus — Visa
Loading live consensus…
Live Wall Street analyst data via Finnhub. Refreshed at most once every 10 minutes. Analyst views change frequently; these are not Vested.blog recommendations. For information only — not investment advice.
Recent news — Visa
Live news feed via TradingView. For information only.
Financials — Visa
Historical financial data via TradingView. For Wall Street analyst consensus and price targets, see your broker, Yahoo Finance, or the company's investor-relations page. For information only.
The 30-second version
- Legal and simple. Buy V via any India-facing platform (Vested, INDmoney) or a global broker (Interactive Brokers, Rovia). Whole shares or a fractional rupee amount.
- It's mostly a capital-gains play with a small dividend. Yield is roughly 0.7%; the bigger capital return is Visa's aggressive buyback program, which keeps shrinking the share count.
- India tax: hold more than 24 months → 12.5% LTCG (no indexation); sell sooner → your slab rate. This is Section 112, not the friendlier 112A that Indian shares get. Dividends are taxed at your slab rate after a 25% US withholding — creditable via Form 67.
- The trap most miss: directly-held V is a US-situs asset — above $60,000, your estate faces up to 40% US estate tax, with no India-US treaty relief.
- If your thesis is "US compounders," VOO and VTI already hold Visa as a top financials weight — same exposure, no single-stock risk.
Quick facts
| Can an Indian resident buy it? | Yes — fully legal under the LRS |
| Ticker / exchange | V / NYSE |
| How | India-facing platform (Vested, INDmoney) or global broker (IBKR, Rovia) |
| Minimum | A fraction of one share (fractional lets you invest an exact rupee amount) |
| Dividend | ~0.7% yield; 25% US WHT, creditable via Form 67 |
| India tax on gains | 12.5% LTCG after 24 months; else your slab (Section 112) |
| Estate-tax risk | US-situs above $60k → up to 40%, no treaty relief |
| Annual compliance | Schedule FA disclosure, every year you hold |
How to buy it — 3 steps
- Open an account + finish KYC. Pick an India-facing platform (Vested, INDmoney) for a simple, India-funded experience, or a global broker (Interactive Brokers, Rovia) for wider access. New to this? Start with how to invest in US stocks from India.
- Fund it via the LRS. Remit from your Indian bank under the LRS (cap: $250,000 per financial year). 20% TCS applies above ₹10 lakh in a year — but it's a creditable prepayment, not a cost. See LRS explained and the LRS & TCS calculator.
- Place the order. One Visa share runs roughly $300–340 in 2026, so a whole share is well within a typical LRS top-up — or buy a fractional rupee amount if you want to size precisely.
The tax that actually matters
Visa pays a small but real dividend (~0.7% yield) and a much bigger capital-gains return over time. Both buckets are taxed in India, under different rules.
Dividends. US withholds 25% at source on dividends paid to Indian residents (treaty rate via W-8BEN). The net dividend is then added to your Indian income at slab; you claim the 25% as a foreign tax credit by filing Form 67 before your ITR — full walkthrough in the dividend withholding and Form 67 guide and the Form 67 FTC calculator.
Capital gains. Under Section 112 (foreign shares don't get the Section 112A treatment Indian-listed equity enjoys):
| Holding period | Treatment | Rate |
|---|---|---|
| 24 months or less | Short-term | Your slab rate (up to ~30%+) |
| More than 24 months | Long-term | 12.5%, no indexation |
Worked example. Buy 5 shares at $320 when USD/INR is 86 → cost ₹1,37,600. Sell 30 months later at $410 when USD/INR is 88 → proceeds ₹1,80,400. Taxable gain ₹42,800; LTCG at 12.5% = ₹5,350. Note the gain is computed in rupees, so the currency move is baked in. Model your own with the US capital-gains calculator; full rules in how US stocks are taxed in India.
The $60,000 estate-tax trap
Directly-held V is a US-situs asset. If the holder dies with more than $60,000 of US-situs assets, the estate faces US estate tax up to 40% — and the India-US treaty does not cover estate tax, so there's no credit or relief. It's the most under-appreciated risk in direct US holding, and the fix (holding through pooled/fund structures instead of direct shares) has to be a deliberate choice made before the position gets large. Full detail: the $60,000 estate-tax trap.
Buy the stock, or get Visa through an ETF?
| If you want… | Best route |
|---|---|
| A concentrated bet that V outperforms financials and the broad market | V directly |
| "Quality US compounders" exposure | VOO or VTI — V is a top financials weight, plus hundreds of others |
| The least single-stock risk | A broad ETF |
Visa is one of the largest financials weights in VOO and VTI, so an S&P 500 or total-market index fund already gives you V exposure proportional to its size. Compare the two routes in direct stocks vs US ETFs and best US ETFs for Indian investors; the broader ETF case is in US ETFs for Indians.
The business in one screen
What it is: Visa runs the rails that move money between cardholders, merchants and banks across more than 200 countries. It doesn't lend or take credit risk — it earns a tiny fee on every transaction, at enormous scale. Operating margins north of 60% are the tell: this is closer to a toll road than a bank.
| Bull case | Bear case |
|---|---|
| Global payments duopoly with Mastercard; deep network-effect moat | Regulators eyeing interchange fees in the US and EU |
| Long cash-to-digital tailwind, especially in emerging markets | Real-time-payment rails (UPI, FedNow, Pix, SEPA Instant) routing around card networks |
| Operating margins above 60%; high incremental returns on capital | FinTech disruption — Stripe, account-to-account, BNPL |
| Aggressive buybacks shrinking the share count | China still effectively closed via UnionPay; geopolitical risk |
Exact valuation is in the live widget above — Visa rarely looks cheap, but it rarely needs to.
Our take
Verdict: BUY — one of the highest-quality businesses in the public market, at a price the long-term math can still justify.
- The moat is durable and wide. A global two-sided network with multi-decade trust, fraud-and-security infrastructure, and regulatory barriers is exceptionally hard to displace; real-time rails chip at the edges but haven't broken the core economics.
- Capital return compounds quietly. A growing dividend plus an aggressive, multi-year buyback program means per-share economics improve even when revenue growth is steady — that's how mid-teens EPS growth gets built on high-single-digit volume growth.
- The risks are real but manageable. Interchange regulation and account-to-account rails are headwinds to model, not theses to short — Visa has absorbed similar pressure for two decades and kept compounding.
Compliance note. Vested.blog is not a SEBI-registered Research Analyst. The above is an editorial opinion for educational illustration only — not investment advice and not a regulated stock recommendation. Vested.blog is published by Rovia; the publisher and its affiliates may hold positions in stocks discussed. Make your own decisions or consult a SEBI-registered advisor.
Risks to size for
- Regulatory: interchange caps or routing mandates in major markets can compress the take rate over time.
- Disintermediation: UPI-style real-time rails won't kill cards globally, but they reset growth expectations in some corridors.
- Currency: your return is in USD but you spend rupees — see the rupee-dollar effect.
Two things people forget
- Schedule FA: disclose V in Schedule FA of your ITR every year you hold it — even if bought and sold within the year, even at a loss. Non-disclosure carries Black Money Act penalties. Use the Schedule FA helper.
- Form 67 before the ITR. To actually claim credit for the 25% US dividend withholding, Form 67 must be filed before you file your income-tax return — miss the order, lose the credit. Full walkthrough: dividend withholding and Form 67.
Bottom line
Buying Visa from India is easy and legal. What needs thought isn't the buying — it's that V is a Section-112 capital-gains play with a 25%-withheld dividend, a US-situs asset with a $60k estate-tax trap, and a single-name bet (high quality, but still single-name). If your real thesis is "US compounders," a broad ETF gives you the exposure without the concentration. For the full picture of accounts and options, start at the US investing hub.
This article is general information, not personalised investment, tax, or legal advice. Rules, rates, and thresholds described here are as of 2026 and can change; verify the current position and consult a qualified advisor before acting.
Run your own numbers
Try the calculator that matches this post
Found this useful? Share it.
Help another Indian working with US RSUs or LRS not get blindsided by this stuff.
About the author

Co-Founder & Chief Executive Officer, Rovia
CFA charterholder, ex-JP Morgan and Makrana Capital. Writes on RSU management, equity comp, and cross-border investments.
More about Shivang →Get more like this in your inbox
One practical post a week on US investing & RSU strategy.
Keep reading
How to buy Eli Lilly (LLY) stock from India
Buy Eli Lilly (LLY) from India via the LRS, in INR. The GLP-1 obesity leader (Mounjaro, Zepbound) with Alzheimer's optionality — the hottest large-cap pharma of the decade, and a dividend grower.
How to buy Vistra Corp (VST) stock from India
Buy Vistra Corp (VST) from India legally via the LRS, in INR. VST is a Texas and Midwest power producer combining nuclear, gas, renewables, and battery storage — a diversified AI-data-centre power play.
How to buy Novo Nordisk (NVO) stock from India
Buy Novo Nordisk (NVO) from India legally via the LRS, in INR. The Ozempic and Wegovy GLP-1 pioneer and Eli Lilly's chief rival — a Danish ADR with its own dividend-withholding and estate-tax quirks Indian holders must navigate.